Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD”

1 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 1 of 1 results

Not applicableNot Yet RecruitingNCT06022744
What this trial is testing

An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD

Who this might be right for
To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 12